In 26 adults with obesity and MASLD undergoing ESG, mean ALT decreased from 59.5 IU/L at baseline to 49.5 IU/L at 6 months and 48.4 IU/L at 12 months (p = 0.001). The gene discussed is GPT; the disease is obesity disorder.